 |
 |
 |
Best of ADA Middle East, Africa & Commonwealth of Independent States
LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
TARGET AUDIENCE
This activity is intended for physicians and other healthcare professionals from the Middle East, Africa and Commonwealth of Independent States, who manage patients with diabetes.
PLANNING COMMITTEE
Robert A. Gabbay, MD, PhD, FACP
Chief Scientific and Medical Officer American Diabetes Association (ADA)
Guillermo E. Umpierrez, MD, CDE
Professor of Medicine Emory University
President-Elect of the American Diabetes Association (ADA)
M. Sue Kirkman, MD
Cardio-Metabolic Liaison Encore Medical Education
| Webinar 1 - Monday, July 5, 2021 (Part I) | |
| 18:00-18:05 | Welcome/Introductions Welcome Video: Ruth Weinstock, MD (ADA President) Moderator: Guillermo Umpierrez, MD |
| 18:05-18:25 | ADA Standards of Care: What’s New in 2021?
Speaker: Jane Reusch, MD |
| 18:25-18:45 | Management of Type 1 Diabetes in Adults—Draft ADA/ EASD Consensus Report
Speaker: Kirsten Nørgaard, MD |
| 18:45-19:00 | Panel Discussion/Q&A
Speakers: Jane Reusch, MD; Kirsten Nørgaard, MD |
| 19:00-19:15 | BREAK |
| Webinar 2 - Monday, July 5, 2021 (Part II) | |
| 19:15-19:20 | Welcome/Introductions
Moderator: Guillermo Umpierrez, MD |
| 19:20-19:40 | Incretin-Based Drugs for Type 2 Diabetes and Beyond
Speaker: Richard Pratley, MD |
| 19:40-20:00 | Covid-19 and Diabetes- An Update
Speaker: Guillermo Umpierrez, MD |
| 20:00-20:15 | Panel Discussion/Q&A
Speakers: Richard Pratley, MD; Guillermo Umpierrez, MD |
| 20:15 | Adjourn/Closing Remarks |
| Webinar 3 - Tuesday, July 6th (Part I) | |
| 18:00-18:05 | Welcome/Introductions
Welcome Video: Ruth Weinstock, MD (ADA President) Moderator: Guillermo Umpierrez, MD |
| 18:05-18:25 | Pros and Cons of Using Point-of-Care HbA1c to Diagnose Diabetes
Speaker: Jay Shubrook, DO |
| 18:25-18:45 | Time in Range and Beyond: Update on Continuous Glucose Monitoring
Speaker: Jeremy Pettus, MD |
| 18:45-19:00 | Panel Discussion/Q&A Speakers: Jay Shubrook, DO; Jeremy Pettus, MD |
| 19:00-19:15 | BREAK |
| Webinar 4 - Tuesday, July 6th (Part II) | |
| 19:15-19:20 | Welcome/Introductions
Moderator: Guillermo Umpierrez, MD |
| 19:20-19:40 | The Pros and Cons of New Approaches to Prevent and Manage Hypoglycemia in Diabetes Therapies
Speaker: Stephanie Amiel, MD |
| 19:40-20:00 | What’s New in Insulin Therapy?
Speaker: Carol H. Wysham, MD |
| 20:00-20:15 | Panel Discussion/Q&A
Speakers: Stephanie Amiel, MD; Carol H. Wysham, MD |
| 20:15 | Adjourn/Closing Remarks |
 |
Stephanie A. Amiel BSc, MD, FRCP Professor of Diabetes Research, King's College London Stephanie Amiel is Professor of Diabetes Research at King’s College London and honorary consultant physician at King’s College Hospital. She trained in medicine with Harry Keen at Guy's Hospital and started researching hypoglycemia in diabetes at Yale, with Robert Sherwin and William Tamborlane, in the early days of insulin pump therapy and the Diabetes Control and Complications Trial (DCCT). Her research has used neuroimaging, structured education, diabetes technologies, islet transplantation and now cognitive approaches to investigate problematic hypoglycaemia, reduce hypoglycemia risk and improve outcomes in type 1 diabetes. She is currently running a randomised controlled trial of a novel intervention for people with treatment-resistant hypoglycemia. She has also researched insulin resistance in appetite control and the impact of ethnicity on dysglycemia. Her clinical work has included running intensified insulin and diabetes pregnancy services. She has over 200 original research papers, book chapters and reviews. She chaired a UK NICE guideline development group on adult type 1 diabetes. She sits on advisory committees including for JDRF and Diabetes UK. She first worked with CDS on the EASD Lilly China programme. She currently chairs the working group for the hypoglycemia track for the annual scientific meeting for ADA. |
 |
Kirsten Nørgaard, MD, DMSc Professor in Clinical Diabetes Technology Senior Consultant, MD, DMSc, MHPE Head of Diabetes Technology Research Steno Diabetes Center Copenhagen, Denmark Kirsten Nørgaard, MD, DMSc is Professor and Senior Consultant at Steno Diabetes Center Copenhagen. The hospital have more than 10.000 attending diabetes patients, hereof 5000 type 1 adults. Approx. 30 % are treated with insulin pumps and 40% with CGM in the type 1 clinic at Steno. Professor Nørgaard is also heading the research group Diabetes Technology Research and has published 150 papers most within this research field. For many years, Dr Nørgaard has been engaged in training health care providers from all over Europe in using technology. Lastly, she has been part of several national and international guideline groups on the use of technology in diabetes treatment. Currently, she is one of the European members in the ADA/EASD guideline group preparing the first common guideline for treatment of type 1 diabetes. |
 |
Richard E. Pratley, MD AdventHealth Samuel E. Crockett Chair in Diabetes Research, Medical Director|AdventHealth Diabetes Inst., Senior Investigator & Diabetes Program Lead|AdventHealth Transl. Research Inst., Adjunct Prof. of Medicine, Johns Hopkins Univ. School of Medicine Dr. Richard Pratley serves as the Samuel E. Crockett Chair in Diabetes Research, Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute, and Medical Director at the AdventHealth Diabetes Institute, in Orlando, Florida. He is also Adjunct Professor of Medicine with the Johns Hopkins University School of Medicine. He is board certified in internal medicine, received his MD from Wayne State University, and completed fellowships in geriatric medicine and gerontology at the University of Michigan, Johns Hopkins University, and the National Institute on Aging. Dr. Pratley is an internationally recognized expert in diabetes. He lectures frequently, has conducted numerous research studies on the pathogenesis, prevention and treatment of diabetes, and has published over 280 peer-reviewed articles on diabetes and its complications. He served as a member of the editorial boards of Diabetes Care, The Lancet: Diabetes and Endocrinology, The Journal of Diabetes and its Complications and The Journal of Clinical Endocrinology and Metabolism, and is an ad hoc reviewer for many other journals. |
 |
Jane EB Reusch, MD Professor of Medicine, Bioengineering and Biochemistry, Associate Director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Rocky Mountain Regional VA Medical Center Jane EB Reusch, MD is a Professor of Medicine, Bioengineering and Integrative Physiology, and Associate Director of the Center for Women’s Health Research, Anschutz Medical Campus and staff physician and merit investigator at the Rocky Mountain Regional VAMC. She is an elected member of American Society for Clinical Investigation, American Association of Physicians, American Diabetes Association 2018 President for Medicine and Science and Fellow of the American Heart Association. She is currently working with the ADA, AHA and ACC on global strategies to decrease the cardiovascular burden of diabetes. She is dedicated to recruiting and mentoring the translational research workforce, especially in women’s health and diabetes. A physician-scientist, Dr. Reusch has made fundamental contributions to our understanding of cellular metabolism of diabetes and its complications. The focus of her basic science program is to identify the cellular and molecular mechanisms (i.e. mitochondrial dysfunction) that contribute to cardiac, vascular, and skeletal muscle dysfunction in diabetes. Her shared clinical translational research program with Dr Judy Regensteiner and Nadeau examines and targets the biological variables in people with diabetes, particularly women, that lead to decreased functional exercise capacity and shortened lifespan. |
 |
Jay H. Shubrook DO, FACOFP, FAAFP Professor, Primary Care Department, Director of Clinical Research and Diabetes Services, Touro University California, College of Osteopathic Medicine Jay H. Shubrook DO, FAAFP, FACOFP is a board-certified Family Physician and a Fellowship trained Diabetologist. He serves as a Professor in the Primary Care Department at Touro University California. He also serves as the Director of Clinical Research and the Director of Diabetes Services at this institution. He is the past Chair of the American Diabetes Association Primary Care Advisory Group and the Associate Editor of Clinical Diabetes. His clinical focus is treatment of all types of diabetes and training the primary care workforce to be better able to help patients manage their diabetes. His research focus is on prevention of and early intervention of type 2 diabetes. |
 |
Guillermo E. Umpierrez, MD, CDE Professor of Medicine, Emory University, ADA President-Elect Dr. Umpierrez is professor of medicine in the division of endocrinology at Emory University School of Medicine, Director of the Grady Memorial Hospital Clinical Research Network, Atlanta-CTSA, and Director of the diabetes and endocrinology section at Grady Memorial Hospital. Dr. Umpierrez first joined the Emory University School of Medicine faculty in 1992. He is a member of the National Board of Directors for the American Diabetes Association and the American Association Clinical Endocrinologists, as well as a member of the Endocrine Society Clinical Guideline Committee and American Association Clinical Endocrinologists Diabetes Scientific Council. His research interests include mechanisms for Beta-cell dysfunction in minority populations and the management of inpatient hyperglycemia. He is a national and international leader in the field of hospital management of diabetes and has published several landmark papers and guidelines in the field of inpatient diabetes. His research program is currently funded by the National Institutes of Health and American Diabetes Association, and by investigator-initiated research trials aiming to determine best insulin protocols for the management of hospitalized patients with diabetes. He heads the Emory Latino Diabetes Education Program, a nationally accredited Spanish Diabetes education program dedicated to providing diabetes education to Latinos. |
 |
Carol H. Wysham, MD Clinical Professor of Medicine, University of Washington School of Medicine, Multicare Rockwood Clinic, Spokane, Washington Carol H. Wysham, MD, is a Clinical Professor of Medicine at the University of Washington School of Medicine and she is a Clinical Endocrinologist at MultiCare/Rockwood Clinic in Spokane, Washington. Dr. Wysham earned her medical degree at the University of Iowa College of Medicine in Iowa City. She completed an internship and residency in Internal Medicine at Oregon Health Sciences University in Portland and a fellowship in Endocrinology and Metabolism at the University of Iowa Hospitals and Clinics in Iowa City. She is certified by the American Board of Internal Medicine with subspecialty certification in Endocrinology and Metabolism. Dr. Wysham is a Fellow of the American College of Physicians, as well as a member of the American Diabetes Association and the Endocrine Society. She has served as member and Chair of the American Diabetes Association Clinical Practice Committee, member, Co-Chair and Chair of the Annual Meeting Steering Committee of the Endocrine Society and is current President-Elect of the Endocrine Society. She has written numerous articles for scientific journals including JAMA, Diabetes Care and Lancet. |
 |
Jeremy Hodson Pettus, MD Assistant Professor, Division of Endocrinology University of California, San Diego Jeremy Pettus, M.D. is an Assistant Professor of Medicine in the Division of Endocrinology at the University of California, San Diego. After being diagnosed with type 1 diabetes himself at the age of 15, Dr. Pettus has dedicated his career toward treating and educating others with the disease. He now specializes in type 1 diabetes clinical and translational research with studies utilizing metabolic techniques such as glycemic clamps to quantify insulin resistance. He also has experience in immunotherapeutics for recently diagnosed patients, islet cell encapsulation/transplantation, and technology-based approaches such as artificial pancreas. In addition to his clinical research at UCSD, Dr. Pettus has interests in patient empowerment through education and works with the not-for-profit organization Taking Control of Your Diabetes (TCOYD.org). With this organization, Dr Pettus speaks at the organization’s patient-centered conferences around the U.S., heading the "Type 1 Diabetes" track at these events. |
This activity is intended for physicians and other health care professionals from Middle East, Africa and Commonwealth of Independent States, who manage patients with diabetes.
Learning Objectives:
Physicians
 |
|
Physicians from Europe
UEMS/ACCME CME credit recognition: The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement, the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.
Successful Completion Statement
Certificates of Completion/Attendance are provided to registered attendees based upon completion of the online evaluation. Invitations will be sent via email and the online evaluation will be open from July 6th,2021 through July 27th, 2021. For questions regarding continuing education, please contact professionaleducation@diabetes.org.
PLANNING COMMITTEE
Robert A. Gabbay, MD, PhD, FACP
Chief Scientific and Medical Officer American Diabetes Association (ADA)
Guillermo E. Umpierrez, MD, CDE
Professor of Medicine Emory University
President-Elect of the American Diabetes Association (ADA)
M. Sue Kirkman, MD
Cardio-Metabolic Liaison Encore Medical Education
PRESENTERS
Stephanie A. Amiel BSc, MD, FRCP
Professor of Diabetes Research, King's College London
Kirsten Norgaard, MD, DMSc
Professor in Clinical Diabetes Technology
Senior Consultant, MD, DMSc, MHPE
Head of Diabetes Technology Research
Steno Diabetes Center Copenhagen, Denmark
Jeremy H. Pettus, MD
Assistant Professor, Division of Endocrinology
University of California, San Diego
Richard E. Pratley, MD
AdventHealth Samuel E. Crockett Chair in Diabetes Research, Medical Director | AdventHealth Diabetes
Institute, Senior Investigator and Diabetes Program Lead | AdventHealth Translational Research
Institute, Adjunct Professor of Medicine, Johns Hopkins University School of Medicine
Jane EB Reusch, MD
Professor of Medicine, Bioengineering and Biochemistry, Associate Director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Rocky Mountain Regional VA Medical Center
Jay H. Shubrook DO, FACOFP, FAAFP
Professor, Primary Care Department, Director of Clinical Research and Diabetes Services, Touro University California, College of Osteopathic Medicine
Guillermo E. Umpierrez, MD, CDE
Professor of Medicine, Emory University, ADA President-Elect
Carol H. Wysham, MD
Clinical Professor of Medicine, University of Washington School of Medicine, Multicare Rockwood Clinic, Spokane, Washington
DISCLOSURE STATEMENT
As a provider of continuing education, it is the Association’s policy to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All participating faculty, course directors, and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
PLANNING COMMITTEE
Robert A. Gabbay, MD, PhD, FACP
Chief Scientific and Medical Officer American Diabetes Association (ADA)
Advisory council member: Onduo, Vida Health, Lark Health
Stock/Share holder: Vida Health, Lark Health
Guillermo E. Umpierrez, MD, CDE
Professor of Medicine Emory University
President-Elect of the American Diabetes Association (ADA)
Research: To Emory University from Novo Nordisk, Astra Zeneca and Dexcom
M. Sue Kirkman, MD
Cardio-Metabolic Liaison Encore Medical Education
Research support: Support to the University of North Carolina from Novo Nordisk, Bayer
PRESENTERS
Stephanie A. Amiel BSc, MD, FRCP
Advisory Council Member: Medtronic, NovoNordisk
Research Support: EU-IMI programme HypoRESOLVE
Kirsten Norgaard, MD, DMSc
Advisory Council Member: Abbott Diabetes Care, Novo Nordisk, Medtronic
Consultant: Novo Nordisk
Speakers Bureau: Sanofi, Novo Nordisk, Medtronic, Abbott
Stock/Shareholder: Novo Nordisk
Research Support: Dexcom, Medtronic, Zealand Pharma
Jeremy H. Pettus, MD
Consultant: Sanofi; Novo Nordisk; Diasome ; Mannkind
Richard E. Pratley, MD
Advisory Panel/Consultant: Corcept Therapeutics Incorporated; Merck; Novo Nordisk; Pfizer; Sanofi; Scohia Pharma Inc.; Sun Pharmaceutical Industries (Dr. Richard Pratley's services were paid for directly to AdventHealth, a nonprofit organization).
Speakers Bureau: Novo Nordisk (Dr. Richard Pratley's services were paid for directly to AdventHealth, a nonprofit organization).
Research Support: Hanmi Pharmaceutical Co; Metavention; Novo Nordisk; Poxel SA; Sanofi (Dr. Richard Pratley's services were paid for directly to AdventHealth, a nonprofit organization)
Jane EB Reusch, MD
Research: CU Foundation CWHR Predoctoral Fellowship (Lilly)*
Advisory Panel/Consultant: Medtronics*
Other: ADA/AHA engagement with Know Diabetes by Heart
(*All resources go to University of Colorado)
Jay H. Shubrook DO, FACOFP, FAAFP
Advisory council member: Novo Nordisk, Bayer
Guillermo E. Umpierrez, MD, CDE
Research: To Emory University from Novo Nordisk, Astra Zeneca and Dexcom
Carol H. Wysham, MD
Abbott, Allergan, Corcept, Eli Lilly, Novo Nordisk, Regeneron
COMMERCIAL SUPPORT
This program is supported by an unrestricted educational grant from: Novo Nordisk
AGENDA
| Webinar 1 - Monday, July 5, 2021 (Part I) | |
| 18:00-18:05 | Welcome/Introductions Welcome Video: Ruth Weinstock, MD (ADA President) Moderator: Guillermo Umpierrez, MD |
| 18:05-18:25 | ADA Standards of Care: What’s New in 2021?
Speaker: Jane Reusch, MD |
| 18:25-18:45 | Management of Type 1 Diabetes in Adults—Draft ADA/ EASD Consensus Report
Speaker: Kirsten Nørgaard, MD |
| 18:45-19:00 | Panel Discussion/Q&A
Speakers: Jane Reusch, MD; Kirsten Nørgaard, MD |
| 19:00-19:15 | BREAK |
| Webinar 2 - Monday, July 5, 2021 (Part II) | |
| 19:15-19:20 | Welcome/Introductions
Moderator: Guillermo Umpierrez, MD |
| 19:20-19:40 | Incretin-Based Drugs for Type 2 Diabetes and Beyond
Speaker: Richard Pratley, MD |
| 19:40-20:00 | Covid-19 and Diabetes- An Update
Speaker: Guillermo Umpierrez, MD |
| 20:00-20:15 | Panel Discussion/Q&A
Speakers: Richard Pratley, MD; Guillermo Umpierrez, MD |
| 20:15 | Adjourn/Closing Remarks |
| Webinar 3 - Tuesday, July 6th (Part I) | |
| 18:00-18:05 | Welcome/Introductions
Welcome Video: Ruth Weinstock, MD (ADA President) Moderator: Guillermo Umpierrez, MD |
| 18:05-18:25 | Pros and Cons of Using Point-of-Care HbA1c to Diagnose Diabetes
Speaker: Jay Shubrook, DO |
| 18:25-18:45 | Time in Range and Beyond: Update on Continuous Glucose Monitoring
Speaker: Jeremy Pettus, MD |
| 18:45-19:00 | Panel Discussion/Q&A Speakers: Jay Shubrook, DO; Jeremy Pettus, MD |
| 19:00-19:15 | BREAK |
| Webinar 4 - Tuesday, July 6th (Part II) | |
| 19:15-19:20 | Welcome/Introductions
Moderator: Guillermo Umpierrez, MD |
| 19:20-19:40 | The Pros and Cons of New Approaches to Prevent and Manage Hypoglycemia in Diabetes Therapies
Speaker: Stephanie Amiel, MD |
| 19:40-20:00 | What’s New in Insulin Therapy?
Speaker: Carol H. Wysham, MD |
| 20:00-20:15 | Panel Discussion/Q&A
Speakers: Stephanie Amiel, MD; Carol H. Wysham, MD |
| 20:15 | Adjourn/Closing Remarks |